Evidence map›Paper›PMID 27139833›Full record

ArticleActa crystallographica. Section F, Structural biology communications2016

1.2 Å resolution crystal structure of the periplasmic aminotransferase PvdN from Pseudomonas aeruginosa.

Eric J Drake, Andrew M Gulick

Open access · bronzeAbstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. The Journal of biological chemistry · 2018
    Article
  4. The biosynthesis of pyoverdines.Microbial cell (Graz, Austria) · 2018
    Review
  5. The periplasmic transaminase PtaA ofThe Journal of biological chemistry · 2017
    Article
  6. Review
  7. PvdN Enzyme Catalyzes a Periplasmic Pyoverdine Modification.The Journal of biological chemistry · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eric J DrakeHauptman-Woodward Institute, 700 Ellicott Street, Buffalo, NY 14203, USA.
Andrew M GulickHauptman-Woodward Institute, 700 Ellicott Street, Buffalo, NY 14203, USA.
University at Buffalo, State University of New York · US

Funding

The Structural Basis for Modular Nonribosomal Peptide SynthesisR01GM116957 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI GULICK, ANDREW M · 2016 to 2019
$1.5M
NIGMS NIH HHS R01 GM116957
6 · The paper itself

Abstract

The Gram-negative pathogen Pseudomonas aeruginosa uses a nonribosomal peptide synthetase (NRPS) biosynthetic cluster for the production of a peptide siderophore. In addition to four multimodular NRPS proteins, the biosynthetic pathway also requires several additional enzymes involved in the production of nonproteinogenic amino acids and maturation of the peptide product. Among the proteins that are required for the final steps in pyoverdine synthesis is PvdN, a pyridoxal phosphate-dependent enzyme that catalyzes an uncharacterized step in pyoverdine production. This study reports the high-resolution structure of PvdN bound to a PLP cofactor solved by multi-wavelength anomalous dispersion (MAD). The PvdN model shows high structural homology to type I aspartate aminotransferases and also contains positive density that suggests an uncharacterized external aldimine.

Indexed as

CatalysisCatalytic DomainCrystallizationCrystallography, X-RayPeriplasmProtein ConformationPseudomonas aeruginosaTransaminasesTransaminasesnonribosomal peptide synthetasePseudomonas aeruginosaPvdNpyoverdine

Identifiers

PMID27139833
PMCPMC4854569
OpenAlexW2336535798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.